The Effects of Piroxicam and Deracoxib on Canine Mammary Tumour Cell Line
Figure 2
Antiproliferative effects of coadministration of piroxicam (Pir) and deracoxib (Der) on canine mammary carcinoma cell line after 72 h incubation. Data are expressed as the percentage of inhibition compared with control in which cell survival was assumed as 100%. ().